Published in AIDS Weekly, February 20th, 2006
In a recently published report from England, investigators conducted a study to "identify factors associated with sustained undetectable viremia after HIV-1 seroconversion in treatment-naive patients, and to describe concomitant CD4 cell count progression."
"Seroconverters enrolled in CASCADE were assumed to control viremia if at least two consecutive viral load measurements were <400/500 copies/ml without treatment. Factors associated with undetectable viremia were identified through a logistic regression.
"A joint model was used to describe simultaneously the CD4 cell...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.